Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations

Shafqat R, Flores-Montanez Y, Delbono V, Nahas SJ

Journal of Pain Research 2020, 13:859-864

Published Date: 30 April 2020